体外式CO2除去装置市場：製品タイプ、アクセス、動作モード、用途、エンドユーザー別-2025-2030年の世界予測

体外式CO2除去装置市場の2024年の市場規模は1億4,755万米ドルで、2025年には1億5,968万米ドルに成長し、CAGRは8.45%、2030年には2億4,018万米ドルに達すると予測されています。

体外式CO2除去装置は、現代の呼吸器ケアにおける重要なソリューションとして登場し、重度の肺疾患に苦しむ患者に戦略的な選択肢を提供しています。近年、この技術は大きな革新と改善を遂げ、臨床医が呼吸困難を管理する方法を変革しています。急性呼吸窮迫症候群（ARDS）、慢性閉塞性肺疾患（COPD）などの疾患の有病率の増加、肺移植への橋渡し需要の高まりはすべて、ダイナミックで競争の激しい市場の拡大に寄与しています。

この分野での進化は、単に技術的な進歩にとどまらず、洗練された設計機能や強化された安全プロトコルの統合にまで及んでいます。最先端の研究開発に支えられたこれらの機器は、体外治療に伴う固有のリスクを最小限に抑えながら、ガス交換プロセスの効率向上を達成しています。自動化と合理化されたプロセスの推進により、手作業による介入への依存度も低下し、信頼性と患者の安全性の両方が強化されています。

さらに、この分野での学際的協力の役割は極めて重要です。工学、臨床の専門知識、そして強固なデータ解析の融合からイノベーションが生まれつつあります。利害関係者は、この結束したアプローチが製品開発を加速させるだけでなく、技術的性能を進化する臨床ニーズと一致させることに気づいています。そのため、この市場は成長の機会であるだけでなく、患者ケアの基準を再定義するチャンスでもあります。本レポートでは、上昇動向、主要なセグメンテーションの洞察、市場に影響を与える変革的シフトを詳細にレビューし、最終的には業界のリーダーや意思決定者にとって不可欠なガイドとなります。

体外式CO2除去装置の情勢における変革期

この業界は、体外式CO2除去技術の情勢を作り変えるような、いくつかの変革的な変化を目の当たりにしてきました。材料科学と生物医学工学の進歩により、メーカーはデバイスの性能を最適化し、より効率的なガス交換と合併症発生率の低減を実現しています。技術的進歩の主な原動力となっているのは自動化であり、コンピュータ制御やリアルタイムモニタリングシステムの強化により、医療従事者は複雑なプロセスをより正確に実行できるようになりました。

経済的な変化も一役買っており、費用対効果を追求する動きは、医療提供者に高い性能と持続可能な運用の両方を実現するイノベーションの採用を迫っています。さらに、患者中心の治療が重視されるようになったことで、効率的なだけでなく低侵襲性の機器開発が促進され、患者の転帰や長時間の治療中の快適性が大幅に改善されました。このような先端技術、経済性、患者ケアの優先事項の総合が、従来のパラダイムからの脱却と次世代ソリューションの採用を市場に促しています。

規制の変化も重要な要因のひとつで、安全性と有効性の基準が厳しくなっているため、メーカー各社は提供する製品を絶えず改良する必要に迫られています。業界関係者、学術機関、臨床専門家間の協力関係の強化は、患者のニーズと治療反応のより豊かで包括的な理解を促進しています。これと並行して、新たなデータ分析とデジタルヘルスアプリケーションが、設計の改善と臨床上の意思決定の両方に役立つ実用的な洞察を提供することによって、補助的な役割を果たしています。こうしたシフトにより、性能と効率の新たなベンチマークが確立され、持続的なイノベーションと市場拡大の道が切り開かれています。

市場セグメンテーションに関する主な洞察

体外式CO2除去の市場セグメンテーションは、多様な力学の微妙な理解を提供します。製品タイプに基づくセグメンテーションは、従来のECCO2R装置から先進的なメンブレンオキシゲーターや洗練されたローラーポンプシステムへの装置の進化を浮き彫りにしており、特に明白です。これと並行して、アクセスに基づくセグメンテーションでは、動静脈と静脈という2つの主要なアプローチを区分しています。それぞれの方法は、患者管理と血行動態管理において実質的に異なる方法論を示しています。

操作様式を検討すると、自動システムと手動システムとの間に明確なコントラストが存在します。この区別は、操作の複雑さを軽減し、全体的なパフォーマンスを向上させるのに役立っている自動化への嗜好が高まっていることを強調するものです。さらに、用途に焦点を移すと、市場は、急性呼吸窮迫症候群への対応、肺移植への橋渡し、慢性閉塞性肺疾患の管理など、明確な使用パターンを特徴付ける。これらの用途は、さらに治療戦略を決定し、機器の設計に影響を与えます。

最後に、エンドユーザー別のセグメンテーションでは、外来手術センターや在宅医療環境から病院や専門クリニックに至るまで、さまざまな医療環境における需要のばらつきが表面化します。これらの各セグメントからは、地域格差、臨床要件、技術導入の可能性に関する独自の洞察が得られます。これらのセグメンテーションパラメータが交差することで、包括的な全体像が描かれ、メーカーや政策立案者が現在および将来の市場ニーズを満たすための戦略を立てる際の指針となります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 急性呼吸不全、重症喘息、COPDの有病率の上昇
    • 非侵襲性CO2除去ソリューションに対するヘルスケア従事者の間での認識の高まり
    • ヘルスケアインフラの拡充と一人当たりの支出の増加
  • 抑制要因
    • ECCO2Rシステムの運用に関連する技術統合リスク
  • 機会
    • 体外式CO2除去装置における技術進歩のための研究開発と資金の増加
    • デバイスの規制製品承認と臨床試験の増加
  • 課題
    • サプライチェーンの複雑さを管理し、遠隔地のヘルスケア現場におけるデバイスの可用性を確保する
• 市場セグメンテーション分析
  • 製品タイプ：重篤な肺合併症の治療のための体外CO2除去におけるECCO2R装置の使用増加
  • 応用：体外式CO2除去装置における急性呼吸窮迫症候群デバイスの適用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 体外式CO2除去装置市場製品タイプ別

• ECCO2Rマシン
• 膜型人工肺
• ローラーポンプ

第7章 体外式CO2除去装置市場アクセス別

• 動静脈
• 静脈静脈

第8章 体外式CO2除去装置市場：運用モード別

• 自動化システム
• 手動システム

第9章 体外式CO2除去装置市場：用途別

• 急性呼吸促拍症候群
• 肺移植への架け橋
• 慢性閉塞性肺疾患

第10章 体外式CO2除去装置市場：エンドユーザー別

• 外来手術センター
• 在宅ケア設定
• 病院
• 専門クリニック

第11章 南北アメリカの体外式CO2除去装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の体外式CO2除去装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの体外式CO2除去装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aferetica Srl
• ALung Technologies, Inc. by LivaNova PLC
• Baxter International Inc.
• Dragerwerk AG & Co. KGaA
• Edwards Lifesciences Corporation
• Estor S.p.A
• Fresenius Medical Care AG
• Getinge AB
• Inspira-Technologies OXY B.H.N. LTD
• Koninklijke Philips N.V.
• LivaNova PLC
• Medica S.p.A
• MicroPort Scientific Corporation
• Nikkiso Co., Ltd.
• NovaLung GmbH
• Terumo Corporation
• X-COR Therapeutics
• XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

• FIGURE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 43. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 70. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 75. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 161. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 181. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 186. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 236. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

The Extracorporeal CO2 Removal Devices Market was valued at USD 147.55 million in 2024 and is projected to grow to USD 159.68 million in 2025, with a CAGR of 8.45%, reaching USD 240.18 million by 2030.

Extracorporeal CO2 Removal Devices have emerged as a critical solution in modern respiratory care, offering a strategic alternative for patients suffering from severe pulmonary conditions. In recent years, this technology has experienced significant innovations and improvements, transforming the way clinicians manage respiratory distress. The increasing prevalence of conditions such as Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), and the rising demand to bridge to lung transplant have all contributed to an expanding market that is both dynamic and highly competitive.

The evolution in this space is not confined merely to technological advancements but extends to the integration of sophisticated design features and enhanced safety protocols. Underpinned by cutting-edge research and development, these devices have achieved improved efficiency in gas exchange processes while minimizing the inherent risks associated with extracorporeal therapies. The drive towards automation and streamlined processes has also reduced the dependency on manual intervention, thereby bolstering both reliability and patient safety.

Furthermore, the role of interdisciplinary collaboration in this sector has been pivotal. Innovations are emerging from an amalgamation of engineering, clinical expertise, and robust data analytics. Stakeholders are finding that this cohesive approach not only accelerates product development but also aligns the technical performance with the evolving clinical needs. As such, the market presents not just an opportunity for growth but also a chance to redefine patient care standards. This report provides an in-depth review of the rising trends, key segmentation insights, and the transformative shifts impacting the market, ultimately serving as an essential guide for industry leaders and decision-makers.

Transformative Shifts in the Landscape of Extracorporeal CO2 Removal Devices

The industry has witnessed several transformative shifts that are reshaping the landscape of extracorporeal CO2 removal technologies. Advances in material sciences and biomedical engineering have allowed manufacturers to optimize device performance, leading to more efficient gas exchange and reduced complication rates. The technological progression is largely driven by an increasing focus on automation, where enhanced computerized controls and real-time monitoring systems empower healthcare professionals to execute complex processes with improved precision.

Economic shifts have also played a role, as the drive for cost-effectiveness pressures providers to adopt innovations that deliver both high performance and sustainable operation. Moreover, the growing emphasis on patient-centered care has catalyzed the development of devices that are not only efficient but also minimally invasive, which significantly improves patient outcomes and comfort during extended therapies. This synthesis of advanced technology, economic prudence, and patient care priorities is driving the market to move away from traditional paradigms and embrace next-generation solutions.

Regulatory changes are another critical factor, with stringent safety and efficacy standards compelling manufacturers to continually refine their product offerings. Increased collaboration between industry players, academic institutions, and clinical experts is fostering a richer, more comprehensive understanding of patient needs and treatment responses. In parallel, emerging data analytics and digital health applications are playing a supplementary role by providing actionable insights that inform both design improvements and clinical decision-making. Such shifts have established a new benchmark for performance and efficiency, carving out a path for sustained innovation and market expansion.

Key Insights into Market Segmentation

Market segmentation within the extracorporeal CO2 removal landscape offers a nuanced understanding of the diverse dynamics at play. The segmentation based on product types is particularly revealing, as it highlights the evolution of devices from traditional ECCO2R machines to advanced membrane oxygenators and sophisticated roller pump systems. In parallel, the segmentation based on access delineates two principal approaches: arteriovenous and venovenous. Each modality represents substantially different methodologies in patient management and hemodynamic control.

Further differentiation is seen when examining the mode of operation, where a distinct contrast exists between automated systems and manual systems. This delineation underscores the growing preference for automation, which has been instrumental in reducing operational complexities and enhancing overall performance. Additionally, when the focus shifts to applications, the market clearly characterizes distinct usage patterns, such as addressing Acute Respiratory Distress Syndrome, providing a bridge to lung transplant, and managing Chronic Obstructive Pulmonary Disease. These applications further dictate the therapeutic strategies and impact the design of devices.

Lastly, segmentation by end user surfaces variations in demand across different care settings, ranging from ambulatory surgical centers and home care settings to hospitals and specialty clinics. Each of these segments provides unique insights concerning regional disparities, clinical requirements, and potential for technological adoption. The intersection of these segmentation parameters paints a comprehensive picture that guides manufacturers and policy makers in tailoring their strategies to meet both current and future market needs.

Based on Product Types, market is studied across ECCO2R Machines, Membrane Oxygenators, and Roller pump.

Based on Access, market is studied across Arteriovenous and Venovenous.

Based on Mode of Operation, market is studied across Automated Systems and Manual Systems.

Based on Application, market is studied across Acute Respiratory Distress Syndrome, Bridge to Lung Transplant, and Chronic Obstructive Pulmonary Disease.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Specialty Clinics.

Significant Regional Insights Shaping the Market

The global landscape for extracorporeal CO2 removal devices reveals considerable regional variations, each contributing distinctively to the overall growth trajectory. In the Americas, the market is characterized by robust healthcare infrastructure and widespread adoption of advanced medical technologies. This region's dynamic regulatory environment and strong emphasis on patient outcomes foster a conducive setting for both established companies and emerging players to invest in innovative solutions.

Across Europe, the Middle East, and Africa, market dynamics are influenced by a confluence of high clinical demand coupled with strategic governmental initiatives. Advanced healthcare systems, in tandem with active research and collaboration networks, are generating significant interest in devices that offer improved safety profiles and operational simplicity. This region's challenges often spur innovative solutions tailored to meet the dual demands of efficacy and cost efficiency.

In Asia-Pacific, rapid economic development and expanding healthcare access are driving market growth. The region combines a high volume of patient populations with an increasing number of private and public healthcare institutions. With a keen interest in incorporating breakthrough healthcare technologies, this market is witnessing accelerated innovations, particularly in terms of integrating automation and digital solutions into device operations. Together, these regional insights underscore a landscape defined by varied clinical practices, economic drivers, and regulatory frameworks, each contributing uniquely to the overall evolution of the market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

A highly competitive environment characterizes the emerging market of extracorporeal CO2 removal devices, where several leading companies are driving forward critical innovations. Industry leaders such as Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., and Dragerwerk AG & Co. KGaA are at the forefront of advancing product capabilities and refining design protocols. At the same time, Edwards Lifesciences Corporation, Estor S.p.A, and Fresenius Medical Care AG have established themselves as key players by focusing on rigorous clinical validations and robust quality standards.

Not far behind are Getinge AB, Inspira-Technologies OXY B.H.N. LTD, and Koninklijke Philips N.V., each contributing uniquely to the technological ecosystem through collaborative research and targeted development projects. Prominent entities such as LivaNova PLC, Medica S.p.A, and MicroPort Scientific Corporation further underscore the sector's dynamism by consistently pushing the envelope on performance enhancements and usability. These companies are complemented by the pioneering efforts of Nikkiso Co., Ltd., NovaLung GmbH, and Terumo Corporation, which have all implemented strategies ranging from strategic partnerships to comprehensive global market deployment.

Other notable contributors include X-COR Therapeutics and XENIOS AG by Fresenius Medical Care AG & Co. KGaA, whose continued commitment to innovation and excellence has helped fortify market positions and drive industry-wide standards. By leveraging advanced research, adaptive manufacturing processes, and expansive clinical networks, these companies have not only set new benchmarks in device efficacy but have also effectively shaped industry trends. Their collective efforts are ensuring that extracorporeal CO2 removal technology remains at the cutting edge of respiratory care solutions.

The report delves into recent significant developments in the Extracorporeal CO2 Removal Devices Market, highlighting leading vendors and their innovative profiles. These include Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Estor S.p.A, Fresenius Medical Care AG, Getinge AB, Inspira-Technologies OXY B.H.N. LTD, Koninklijke Philips N.V., LivaNova PLC, Medica S.p.A, MicroPort Scientific Corporation, Nikkiso Co., Ltd., NovaLung GmbH, Terumo Corporation, X-COR Therapeutics, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA. Actionable Recommendations for Industry Leaders

Industry leaders should consider a strategic roadmap that embraces both innovation and operational efficiency to remain competitive in the evolving market of extracorporeal CO2 removal devices. It is recommended that companies invest in robust research and development programs to harness the benefits of automation and digital integration, which have been shown to enhance device reliability and patient safety. By focusing on continuous improvement in performance, companies can address the growing clinical needs effectively and maintain regulatory compliance.

Moreover, a diversified market approach that leverages insights from key segmentations-ranging from product type and access method to mode of operation, application, and end-user preferences-is essential. Organizations need to capitalize on the data-driven trends that point to the rising demand for automated systems and minimally invasive technologies. Building strategic alliances with clinical experts and academic institutions can further aid in refining design specifications and fast-tracking product innovation.

Navigating regional differences by tailoring solutions to meet specific market demands is crucial. Companies should adopt targeted marketing strategies in regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific, while remaining agile in response to evolving local regulatory frameworks. Embracing a customer-centric approach, with a focus on post-market surveillance and real-time feedback, will enable continuous enhancements and foster greater consumer trust. In summary, a balanced investment in technology, collaboration, and regional market intelligence will help solidify long-term competitive advantages.

Conclusion: A Future Poised for Innovation and Growth

In conclusion, the landscape of extracorporeal CO2 removal devices is undergoing significant transformation, driven by technological advancements, diversified market segmentations, and dynamic regional trends. The evolution from traditional solutions to more automated, efficient, and patient-friendly systems underscores the significant progress made in the field. With heightened regulatory scrutiny and the ongoing commitment of leading companies towards innovation, the industry is positioned for robust growth.

This comprehensive analysis reveals that harnessing the potential of emerging technologies while recognizing the unique clinical demands across regions is key to sustaining success. Industry stakeholders are well-advised to leverage actionable insights derived from market segmentation and regional analyses. With strategic investments and collaborative efforts, the market can achieve unprecedented levels of performance and efficiency, ultimately redefining standards in respiratory care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of acute respiratory failure, severe asthma, and COPD
    • 5.1.1.2. Growing awareness among healthcare professionals about non-invasive CO2 removal solutions
    • 5.1.1.3. Increasing healthcare infrastructure and rise in per capita expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Technical integration risk associated with operating ECCO2R systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D and funding for technological advancements in extracorporeal CO2 removal devices
    • 5.1.3.2. Increasing regulatory product approval and clinical trials for the device
  • 5.1.4. Challenges
    • 5.1.4.1. Managing supply chain complexities and ensuring device availability in remote healthcare settings
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Types: Growing usage of ECCO2R machines in extracorporeal CO2 removal to treat severe pulmonary complications
  • 5.2.2. Application: Expanding application of Acute respiratory distress syndrome devices in extracorporeal CO2 removal devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Extracorporeal CO2 Removal Devices Market, by Product Types

• 6.1. Introduction
• 6.2. ECCO2R Machines
• 6.3. Membrane Oxygenators
• 6.4. Roller pump

7. Extracorporeal CO2 Removal Devices Market, by Access

• 7.1. Introduction
• 7.2. Arteriovenous
• 7.3. Venovenous

8. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

• 8.1. Introduction
• 8.2. Automated Systems
• 8.3. Manual Systems

9. Extracorporeal CO2 Removal Devices Market, by Application

• 9.1. Introduction
• 9.2. Acute Respiratory Distress Syndrome
• 9.3. Bridge to Lung Transplant
• 9.4. Chronic Obstructive Pulmonary Disease

10. Extracorporeal CO2 Removal Devices Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Home Care Settings
• 10.4. Hospitals
• 10.5. Specialty Clinics

11. Americas Extracorporeal CO2 Removal Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Extracorporeal CO2 Removal Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal CO2 Removal Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Inspira Technologies enhances its INSPIRA ART100 system with advanced alarm troubleshooting and automated critical care guidance
  • 14.3.2. NSW launches mobile ECMO referral service that deploys specialist pediatric teams for immediate lifesaving care
  • 14.3.3. The ROMEO trial secured GBP 2.1 million in NIHR funding
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aferetica Srl
• 2. ALung Technologies, Inc. by LivaNova PLC
• 3. Baxter International Inc.
• 4. Dragerwerk AG & Co. KGaA
• 5. Edwards Lifesciences Corporation
• 6. Estor S.p.A
• 7. Fresenius Medical Care AG
• 8. Getinge AB
• 9. Inspira-Technologies OXY B.H.N. LTD
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Medica S.p.A
• 13. MicroPort Scientific Corporation
• 14. Nikkiso Co., Ltd.
• 15. NovaLung GmbH
• 16. Terumo Corporation
• 17. X-COR Therapeutics
• 18. XENIOS AG by Fresenius Medical Care AG & Co. KGaA